Total synthesis and dual PPARα/γ agonist effects of Amorphastilbol and its synthetic derivatives
Authors:
- Woojung LeeWLWoojung Lee
- Kyu Hyuk JeongKJKyu Hyuk Jeong
- Jung Ho SongJSJung Ho Song
- Soon-Hye ParkSPSoon-Hye Park
- Pilju ChoiPCPilju Choi
- Su-Nam KimSKSu-Nam Kim
- Seokjoon LeeSLSeokjoon Lee
- Jungyeob HamJHJungyeob Ham
- 1 June 2012
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 22 (12) , 4122-4126
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- The peroxisome proliferator-activated receptor β/δ (PPARβ/δ) agonist GW501516 prevents TNF-α-induced NF-κB activation in human HaCaT cells by reducing p65 acetylation through AMPK and SIRT1Biochemical Pharmacology, 2011
- Metabolic and nonmetabolic regulatory functions of peroxisome proliferator-activated receptor βCurrent Opinion in Lipidology, 2010
- Covalent Peroxisome Proliferator-activated Receptor γ Adduction by Nitro-fatty AcidsJournal of Biological Chemistry, 2010
- A Novel Class of Antihyperlipidemic Agents with Low Density Lipoprotein Receptor Up-Regulation via the Adaptor Protein Autosomal Recessive HypercholesterolemiaJournal of Medicinal Chemistry, 2010
- IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK ratProceedings of the National Academy of Sciences, 2009
- Effects of Momordica charantia on insulin resistance and visceral obesity in mice on high-fat dietDiabetes Research and Clinical Practice, 2008
- Learning from tesaglitazarDiabetes & Vascular Disease Research, 2007
- Adipocytes as regulators of energy balance and glucose homeostasisNature, 2006
- Pomegranate flower improves cardiac lipid metabolism in a diabetic rat model: role of lowering circulating lipidsBritish Journal of Pharmacology, 2005
- Fenofibrate and Rosiglitazone Lower Serum Triglycerides with Opposing Effects on Body WeightBiochemical and Biophysical Research Communications, 2000